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ABSTRACT
Various natural biological conduits have been investigated to bridge peripheral nerve injury especially in critical 
gap (greater than 3 cm in human). Autograft, the current gold standard, has several drawbacks including limited 
availability of donor graft, donor-site morbidity and mismatch in size in clinical practices. The aim of this study was 
to analyze the development of nerve conduit using decellularized human umbilical cord (HUC) artery seeded with 
neurodifferentiated human MSCs (ndMSCs) in bridging peripheral nerve gap. Artery conduits obtained from HUC were 
decellularized to remove native cells (n=3), then characterized by Hematoxylin and Eosin (H&E) staining and nuclei 
counterstaining with DAPI. The decellularized artery conduit was measured for every 2 weeks until 12 weeks. Next, 
mesenchymal stem cells (MSCs) were differentiated into neural lineage using 400 µg/mL of Centella asiatica. Then, 
1.5×106 of MSCs or ndMSCs were seeded into decellularized artery conduit to study cell attachment. H&E staining 
and nuclei counterstaining with DAPI showed that all cellular components were removed from the HUC arteries. The 
decellularized artery conduit did not collapse and the lumen remained rigid for 12 weeks. Immunocytochemistry 
analysis with neural markers namely S100β,  P75 NGFR, MBP and GFAP showed that MSCs had differentiated into 
neural lineage cells. H&E staining showed that the seeded MSCs and ndMSCs attached to the lumen of the conduits 
as early as 2 days. In conclusion, this study showed that nerve conduit using decellularized HUC artery seeded with 
neurodifferentiated human MSCs was successfully developed and have the potential to bridge critical nerve gap.
Keywords: C. asiatica; mesenchymal stem cells; nerve conduit; nerve injury; umbilical cord artery
ABSTRAK
Pelbagai konduit biologi semula jadi telah dikaji untuk menyambungkan semula kecederaan saraf periferi terutamanya 
yang bersaiz kritikal (lebih daripada 3 cm pada manusia). Rawatan piawai pada masa kini adalah pemindahan autograf, 
tetapi ia mempunyai beberapa kelemahan dalam amalan klinikal seperti kekurangan tisu penderma, morbiditi pada 
tapak penderma dan saiz tisu yang tidak sepadan. Tujuan kajian ini dijalankan adalah untuk mengkaji perkembangan 
konduit saraf menggunakan arteri tali pusat manusia yang telah dinyahsel dan disemai dengan sel saraf yang 
terbeza daripada sel stem mesenkima. Konduit arteri tali pusat manusia yang telah dinyahsel (n=3) seterusnya dikaji 
keberkesanannya menggunakan pewarnaan Hematoxylin dan Eosin (H&E) dan pewarnaan nukleus oleh DAPI. Konduit 
arteri itu kemudiannya diukur kepanjangan pada setiap 2 minggu sehingga 12 minggu. Aruhan pembezaan sel saraf 
daripada sel stem mesenkima telah dilakukan melalui penggunaan 400 µg/mL C. asiatica. Kemudian, 1.5×106  sel stem 
mesenkima atau sel saraf disemai ke dalam konduit arteri untuk mengkaji perlekatan sel. Pewarnaan Hematoxylin dan 
Eosin (H&E) dan DAPI pada nukleus menunjukkan bahawa semua komponen sel telah berjaya dinyahkan daripada 
arteri tali pusat manusia. Konduit arteri itu tidak menguncup dan lumennya kekal tegar selama 12 minggu. Analisis 
immunositokimia menggunakan penanda saraf iaitu  S100β, P75 NGFR, MBP dan GFAP mendedahkan bahawa sel stem 
mesenkima telah terbeza kepada leluhur sel saraf. Pewarnaan H&E menunjukkan bahawa sel stem mesenkima dan 
sel saraf yang telah disemai melekat pada dinding lumen konduit tersebut seawal hari ke-dua. Secara kesimpulannya, 
kajian ini menunjukkan bahawa konduit saraf menggunakan arteri tali pusat manusia dan disemai dengan sel saraf 
yang terbeza daripada sel stem mesenkima telah berjaya dihasilkan dan berpotensi untuk diimplan pada kecederaan 
saraf periferi bersaiz kritikal. 
Kata kunci: Arteri tali pusat; C. asiatica; kecederaan saraf; konduit saraf; sel stem mesenkima
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INTRODUCTION
Insufficient functional restoration associated with 
peripheral nerve injury (PNI) has been a significant critical 
issue which sometime resulted to permanent disability. 
It was estimated that 50000 procedures were performed 
annually to repair damaged peripheral nerves at the 
cost of USD 7 billion per year (Liao et al. 2013). Despite 
rapid clinical advancement, the treatment of PNI is still a 
challenge especially in critical gap (greater than 3 cm) 
(Kaizawa et al. 2017; Liao et al. 2013). This condition is 
worsened by the limited regeneration of peripheral nerve 
that depends on several factors including the length of 
injury, presence of neurotrophic factors and Schwann 
cells (Höke 2006). The current gold standard procedure 
to bridge critical gap of PNI is the use of autologous nerve 
grafts, where the sural nerve is the most commonly used 
autograft (Ray et al. 2010). Albeit its success in nerve 
regeneration and restoration of functional recovery is well 
documented, nerve autografting has several drawbacks 
including limited availability of donor graft, mismatch in 
size in clinical practice, additional surgery trauma at donor 
sites and associated functional loss of donor nerve (Gordon 
et al. 2003; Zhan et al. 2013). 
 In the attempt to avoid the shortcomings of nerve 
autograft, researchers have focus their attention to 
the development of nerve conduits. Food and Drug 
Administration (FDA), has approved several nerve 
conduits made of natural polymers, NeuraGen, NeuroFlex, 
NeuroMatrix (Type 1 Collagen) and synthetic polymers, 
Neurotube (PGA) and Neurolac (caprolactone) (Deal 
et al. 2012; Kehoe et al. 2012). A study reported that 
collagen coated PLGA nerve conduit seeded with neural 
differentiated mesenchymal stem cells is suitable for use 
as artificial nerve conduit (Hidayah et al. 2012; Sulong et 
al. 2014). However, several disadvantages accompanying 
with synthetic nerve conduits have hindered its optimal 
functional recovery including chronic inflammation, acidic 
degradation by-product and rigidity mismatch (Deal et al. 
2012; Liao et al. 2013). 
 As an alternative, studies have been made on the use of 
natural biological nerve conduits for example vein, artery 
and fibroblast-made scaffold. The use of vein graft has 
shown effective results to treat nerve damage and enhance 
functional recovery in in vivo study (Hassan et al. 2012; 
Lokanathan et al. 2014). However, several problems related 
with unmodified veins including; easily collapse and the 
presence of valves found to block axonal regeneration 
(Crouzier et al. 2009). On the other hand, the use of arterial 
graft seems to be gaining attention because of the few 
adding advantages, such as wall thickness, permeability 
and mechanical rigidity. Earlier study reported that artery 
conduit seeded with mesenchymal stem cells enhanced 
significantly axonal regeneration and prevented muscular 
atrophy (Liao et al. 2013). Sun et al. (2011) reported 
that the use of decellularized artery conduit seeded with 
differentiated adipose derive stem cell resulted in better 
nerve regeneration and functional recovery. Apparently, 
human umbilical cord (HUC) artery might represent a good 
source as a nerve conduit as it is easily obtainable, simply 
isolated and lack branches (Mallis et al. 2014). The HUC 
collected from health centres were redundant and often 
disposed as biological samples.
 The use of allograft might provoke immunological 
response and the recipients  should be under 
immunosuppressive drugs for a certain time. This issue 
can be avoidable by decellularization process, where this 
process removes native cells, residual blood and other 
soluble components leaving the extracellular matrix 
(ECM) that remained intact (Mallis et al. 2014; Quint et 
al. 2011; Tuan-Mu et al. 2014). Besides, decellularized 
blood vessels maintained their three dimensional structure 
and reduce immunogenicity (Rodríguez-Rodríguez et 
al. 2017). Furthermore, decellularized materials can 
be seeded with various cells and supplied with growth 
factors to mimic native tissue and consequently generate 
functional tissue (Gui et al. 2009). 
 On the other hand, the medicinal use of Centella 
asiatica (L.) or is also known as pegaga in Malaysia, 
Brahmi  in Unani medicines, Mandookaparni  in 
Ayurveda, Gotu Kola or Indian Pennywort in the 
western world (Jamil et al. 2007), has been long 
documented in the previous studies. An accumulating 
evidence has demonstrated that this herbal medicine 
has neuroprotective and neuroregenerative properties 
(Lokanathan et al. 2016; Omar et al. 2011). A study 
found that the bioactive compound present in C. asiatica 
fresh leaf juice has neuronal dendritic growth stimulating 
property, which act as neuronal basis for enhancing 
learning and memory (Mohandas et al. 2009). Another 
study showed that the treatment of C. asiatica ethanolic 
extract in rats demonstrated more rapid functional 
recovery and increased axonal regeneration, indicating 
that the axons grew at a faster rate, pointed out its 
neuroregenerative properties (Soumyanath et al. 2005). 
These remedial values were believed to have been largely 
contributed by its bioactive components namely asiatic 
acid, madecassic acid, asiaticoside and madecassoside 
(Puttarak et al. 2016). 
 The beneficial use of C. asiatica is not limited to just 
neural properties, this plant has several other advantages 
including on wound healing of skin, oxidative stress, 
anti-inflammatory, anti-depressant, sedative, gastric 
ulcer, memory-enhancing, anti-diabetic, cardioprotective, 
hepatoprotective and immunomodulation (Nurlaily et al. 
2012; Ruszymah et al. 2012; Said 2009; Somboonwong et 
al. 2012; Tiwari et al. 2011). Despite its good values, C. 
asiatica however exert some negative effects in terms of 
antifertility in male mice and anti-proliferative activities 
on cells (Mohd Heikal et al. 2014; Noor et al. 2004). Thus, 
it is important to determine the optimal concentration of 
C. asiatica in order to gain its fully benefit. 
 Our in vitro study has confirmed that minimal 
dose of C. asiatica (400 μg/mL) has the capacity to 
differentiate human Wharton’s Jelly mesenchymal stem 
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cells into Schwann cells or other neural lineage cells 
(Norazzila et al. 2018, 2017). Thus, the focus of this 
study was to develop decellularized human umbilical 
cord artery seeded with 400 μg/mL C. asiatica induced 
- neurodifferentiated human MSCs (ndMSCs) as an 
alternative nerve conduit for peripheral nerve injury.
MATERIALS AND METHODS
DECELLULARIZATION OF THE HUMAN                        
UMBILICAL CORD ARTERY
This study was conducted at Universiti Kebangsaan 
Malaysia Medical Centre, Malaysia. All samples were 
collected with informed consent from patients and 
approved by Research Ethics Committee of Universiti 
Kebangsaan Malaysia (UKM) (no. FF-2017-175). Human 
umbilical cord (HUC) samples (n=3) were obtained from 
healthy patients undergoing full term elective caesarean 
delivery. After collection, the HUC were rinsed several 
times with sterile Dulbecco’s phosphate buffer saline 
(DPBS) (Sigma Aldrich, USA) to wash any bloodstains. 
The HUC samples were dissected and stripped off the 
arteries and vein. The Wharton’s jelly part was kept for 
mesenchymal stem cells isolation. The decellularization 
process of the HUC arteries was done based on previously 
published protocol (Sun et al. 2011). After cleaning them 
off blood and connective tissue, the arteries were rinsed 
in sterile ice-cold saline. Then, they were decellularized 
with 0.025% trypsin-ethylenediaminetetraacetic acid 
(EDTA) (Sigma Aldrich, USA) in DPBS for 1 h, deionized 
distilled water (ddH2O) for 2 h, 1% detergent Triton 
X-100 (Sigma Aldrich, USA) in DPBS for 4 h, ddH2O for 
1 h and 1% sodium dodecyl sulfate (SDS) (Sigma Aldrich, 
USA) in DPBS for 4 h. All procedures were performed 
under sterile conditions with continuous shaking at 37°C. 
The decellularized HUC arteries were then sterilized with 
70% alcohol (SYSTERM, Malaysia) (3 × 15 min each), cut 
approximately 2 cm each and analysed using Hematoxylin 
& Eosin (H&E) (Richard-Allan Scientific, USA) staining 
and nuclei counter-staining with DAPI (Invitrogen, USA). 
HEMATOXYLIN AND EOSIN (H&E) STAINING AND NUCLEI 
COUNTER-STAINING WITH DAPI (4’,6-DIAMIDINO-2-
PHENYLINDOLE) OF THE DECELLULARIZED HUC ARTERY
The decellularized and native arteries (control) were fixed 
with 10% formalin (Leica Biosystems, USA) for 24 h. The 
arteries were then rinsed with DPBS and processed using 
a series of chemicals, 50% and 70% alcohol (MERCK, 
Germany) (1 h each), 95% alcohol (1.5 h), absolute alcohol 
(3 × 1 h, 1.5 h and 1.5 h), equal part alcohol:toluene (1.5 
h), toluene (3 × 1 h, 1.5 h and 1.5 h) and paraffin wax (2 
× 2 h each). Then, tissues were embedded using paraffin 
wax for histological analysis. Tissue sections of 2-5 μm 
thin were cut using a microtome (Leica, Germany). The 
tissue sections were then dewaxed and dehydrated with a 
series of chemicals; xylene (J.T. Baker, USA) (3 × 5 min 
each) and alcohol (100%, 95% and 70%) (3 min each) 
followed by Hematoxylin staining (10 min) and Eosin 
staining (4 min). Lastly, the tissue sections were rehydrated 
with alcohol (95% and 100%) (3 min each) and xylene (3 
× 5 min each). The tissue sections were mounted using 
mounting solution and observed under light microscope 
(OLYMPUS, CH30). For nuclei counterstaining with DAPI, 
after dehydration, tissue sections were permeabilized with 
0.5% Triton X-100 for 20 min and incubated with DAPI 
(1/15000) for 40 min in the dark at room temperature. 
Next, tissues sections were mounted and observed under 
fluorescence microscope (Nikon, ECLIPSE Tἰ).
MEASUREMENT OF LENGTH OF                         
DECELLULARIZED HUC ARTERY
1.5 cm of HUC arteries conduit was put in low-glucose 
Dulbecco’s modified Eagle medium (DMEM-LG) (Gibco, 
USA) complete medium (containing 10% fetal bovine 
serum (FBS) (Gibco, USA), 1% Glutamax (Gibco, USA) 
and 1% antibiotic-antimycotic (Gibco, USA) at 37°C in 
humidified 5% CO2 incubator (New Brunswick Galaxy® 
170 Series, Eppendorf, USA) and the length was measured 
up every 2 weeks until 12 weeks. 
ISOLATION AND PROPAGATION OF HUMAN WHARTON’S 
JELLY MESENCHYMAL STEM CELLS (hWJMSCs)
The human Wharton’s Jelly samples were processed within 
3 h of collection as prescribed in the previous study (Lim 
et al. 2016). The Wharton’s Jelly was minced and digested 
with 0.6% Collagenase Type 1 (Worthington, USA) in 
incubator shaker (250 rpm) at 37°C for 2 h. After complete 
digestion, the digested tissue was centrifuged at 5000 rpm 
for 5 min to obtain cell pellet. The cell pellet was washed 
with DPBS and subjected for another centrifugation. Then, 
the cell pellet was resuspended in DMEM-LG complete 
medium and cultured in T-25 cm² culture flask (Corning, 
USA) at 37°C in humidified 5% CO2 incubator for 
expansion. Culture medium was changed every 3 days. 
Once it reached 80% confluency, it was detached using 
0.05% trypsin and expanded into new flasks at a density 
of 5 × 10³ cells/cm². To ensure the consistency, passage 3 
cells were used throughout the experiment.
NEURODIFFERENTIATION OF MSCS USING                                 
400 ΜG/ML C. ASIATICA
The differentiation of hWJMSCs into neural lineage was 
performed using C. asiatica in the concentration of 400 
μg/mL, as prescribed in the previous study (Norazzila et 
al. 2018). Before induction, MSCs were seeded at a density 
of 5 × 10³ cells/cm² in a 6 well plate (Thermo Scientific, 
Denmark) and cultured for 2 days for attachment. Then, 
for the experimental group, the cells were cultured in 
α-MEM LG (Gibco, USA) complete medium supplemented 
with 400 μg/mL C. asiatica. For the negative control 
group, cells were cultured in α-MEM LG complete medium 
only. Schwann cells purchased from ScienCell, USA and 
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cultured in specific Human Schwann Cell Medium (SCM) 
(ScienCell, USA) served as the positive control group. The 
cells were treated for 9 days. 
IMMUNOCYTOCHEMISTRY (ICC) ANALYSIS OF 
NEURODIFFERENTIATED MSCs (ndMSCs)
The ndMSCs was evaluated based on the expression 
of neural markers using ICC analysis. The markers 
investigated are calcium-binding protein B (S100β), p75 
nerve growth factor receptor (p75 NGFR), myelin basic 
protein (MBP) and glial fibrillary acidic protein (GFAP). 
After 9 days of treatment, all cells were washed with DPBS 
and fixed with 4% paraformaldehyde (PFA) (Sigma Aldrich, 
USA) for 24 h. The next day, cells were washed with DPBS (3 
× 5 min each) and permeabilized with 0.5% Triton X-100 
for 20 min. Cells were then washed with washing solution, 
0.1% Tween 20 (Sigma Aldrich, USA) (3 × 5 min each) and 
blocked with 10% goat serum (Gibco, New Zealand) for 
1 h at 37°C. Next, cells were incubated overnight at 4°C 
with the following primary antibodies: mouse monoclonal 
anti-S100β (1/1000) (Abcam, UK), rabbit polyclonal anti-
NGF p75 receptor (1/500) (Abcam, UK), mouse monoclonal 
anti-MBP (1/1000) (Thermo Fisher Scientific, USA) and 
mouse monoclonal anti-GFAP (2.5 μg/mL) (STEMCELL 
Technologies, Canada). On the next day, cells were washed 
with washing solution, 0.1% Tween 20 (3 × 5 min each) 
and incubated with the secondary antibody, Goat Anti-
Mouse IgG (Texas Red) (1/300) (Abcam, UK) or Goat 
Anti-Rabbit IgG (FITC) (1/300) (Abcam, UK), at 37°C for 
2 h. Nuclei were counter-stained with DAPI for 40 min in 
the dark at room temperature. Cells were examined under 
fluorescence microscope.
SEEDING OF MSCS AND NDMSCS INTO DECELLULARIZED 
HUC ARTERY CONDUIT
Arteries were cut approximately 1.5 cm each and MSCs 
or ndMSCs were seeded into the conduit. Briefly, the 
cell pellet containing 1.5 × 106 of MSCs or ndMSCs were 
resuspended in 20 μL of FBS and seeded directly into the 
lumen of the conduit using p200 micropipette (Eppendorf, 
Germany). The MSCs seeded conduit (MC) or ndMSCs 
seeded conduit (NC) were then cultured for another 2 days 
at 37°C in humidified 5% CO2 incubator to enable cell 
attachment before conduit implantation. 
H&E STAINING OF MSCS SEEDED CONDUIT (MC) AND 
NDMSCS SEEDED CONDUIT (NC) (PRE-GRAFTING)
After seeding, H&E staining was done to evaluate the MC 
and NC histological structure before implantation. After 2 
days in incubation, the MC or NC was first fixed with 10% 
formalin for 24 h. The protocol for H&E staining was used 
as previously discussed.
RESULTS AND DISCUSSION
The efficiency of decellularization process of the human 
umbilical cord (HUC) arteries and cell seeding attachment 
play a vital role in developing nerve conduit. This study 
was performed to analyze the development of nerve 
conduit using decellularized human umbilical cord (HUC) 
artery seeded with neurodifferentiated human MSCs 
(ndMSCs) in bridging peripheral nerve gap. To investigate 
the effectiveness of a developed nerve conduit, H&E 
staining, nuclei counterstaining with DAPI, measurement 
of the length of artery conduit and in vitro evaluation of 
constructed nerve conduit were performed. 
DECELLULARIZATION AND DEVELOPMENT OF THE HUC 
ARTERY
Freshly isolated HUC were dissected to collect arteries 
inside (Figure 1(A)) and directly cleaned from blood 
and connective tissue (Figure 1(B)). After various stages 
of processing, the decellularized HUC arteries did not 
collapse and the lumen remained rigid (Figure 1(C)). 
This could be due to the extracellular matrix (ECM) of the 
HUC arteries were retained during the decellularization 
process. There were two arteries reside within HUC while 
there was only one vein. The HUC arteries have thicker 
muscular wall compared to HUC veins and it did not 
have branches. The decellularization process removed all 
cellular and nuclei material. In this study, the HUC arteries 
were decellularized with a combination of enzymatic and 
detergent as it improved decellularization efficiency and 
retained appropriated extracellular matrix content (Gilpin 
FIGURE 1. Human umbilical cords (HUC) arteries after various stages of processing (A) HUC after dissecting to 
collect arteries inside. Arrow shows the HUC arteries (B) HUC arteries after cleaning 
of blood and connective tissue and (C) Decellularized artery conduit
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et al. 2017). The HUC arteries have a uniform diameter 
of 1.5 mm under collapsed conditions and 4.5-5.5 mm 
under physiological pressure as stated in aforementioned 
study (Gui et al. 2009). Similarly with this study, the HUC 
arteries has unique criteria of long graft without branches 
and has similar dimensions with peripheral nerve (Tuan-
Mu et al. 2014). Besides, HUC was not frozen before 
decellularization as a study reported that the efficiency 
of decellularization were reduced when frozen HUC were 
used (Tuan-Mu et al. 2014).
HEMATOXYLIN & EOSIN (H&E) STAINING AND NUCLEI 
COUNTER STAINING WITH DAPI OF DECELLULARIZED          
HUC ARTERY CONDUIT
The HUC arteries decellularization efficiency was evaluated 
by staining of the nuclear and cellular components. H&E 
staining was done to compare the existence of cellular 
components between the native artery (Figure 2(A) & 
2(C)) and decellularized artery (Figure 2(B) & 2(D)). H&E 
staining showed the cellular components did not exist in 
decellularized artery as compared to native artery. Nuclei 
counterstaining with DAPI added another prove that nuclear 
material was absence after decellularization (Figure 2(F)) 
as compared to native artery (Figure 2(E)). After various 
stages of processing and decellularizing for 12 h, the 
cellular and nuclear material was completely removed 
and non-detectable in the vessel wall. This indicated the 
removal of smooth muscle cells and endothelial cells 
(native cell) from the vessel wall of the HUC artery. The 
extracellular matrix and basement membrane of the 
decellularized artery on the other hand remained intact 
and preserved (Figure 2(B), 2(D) & 2 (F)). 
 Previous study stated that the decellularization 
process that used SDS solution was effective in reducing 
cellular content. The decellularization process removed 
immunogenic cells, other soluble components of the matrix 
and enhanced permeability (Crouzier et al. 2009). Another 
study reported that the extra cellular matrix of collagen 
fibers was well preserved of a decellularized HUC artery. 
The decellularized HUC artery minimized immunogenicity, 
supported cell seeding and could be stored for a long 
term (Gui et al. 2009). In addition, decellularized HUC 
artery lacking of cellular and nuclear residues thus 
make it suitable for developing nerve graft (Mallis et al. 
2014). Based on the results of H&E staining and nuclei 
counterstaining with DAPI in this study, it is concluded that 
by decellularization process, all residual blood, cells and 
other soluble components have been successfully removed. 
This technique is important to prevent any rejection during 
subsequent implantation in clinical use.
FIGURE 2. H&E staining and nuclei counterstaining with DAPI of the native artery (control) and 
decellularized artery. (A, B, C, D) H&E staining of arteries, (E, F) nuclei counterstaining with DAPI 
of the arteries. H&E staining showed no cellular components were detectable in decellularized 
artery (B, D) compared to native artery (A, C). Nuclei counterstaining with DAPI demonstrated 
that the nuclear materials were removed in decellularized artery (F) compared to native artery 
(E). T = transverse section, L = longitudinal section. Magnification, 10 × Scale bar, 100 μm 
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MEASUREMENT OF LENGTH OF DECELLULARIZED HUC 
ARTERY CONDUIT
After 12 weeks in incubation, the decellularized HUC artery 
conduit did not degrade and swell. The decellularized 
HUC artery conduit also did not collapse and the length 
remained almost the same throughout the whole study. 
Only a small change (11.8% ± 1.85) was recorded and it is 
negligible (Figure 3). Furthermore, the decellularized HUC 
artery conduit maintained its shape and three-dimensional 
properties. The maintaining of the length and shape of 
the decellularized HUC artery conduit could be due to 
preserved ECM during decellularization process and the 
thick muscular wall of the artery vessels. Thick muscular 
wall of the arteries could prevent degradation and muscular 
infiltration during clinical implantation in the nerve area. 
A few studies have accumulated the evidence of the 
good biomechanical strength of decellularized arteries. 
Consistent with our findings, a study mentioned that 
decellularized arteries or blood vessels maintained their 
three dimensional properties (Rodríguez-Rodríguez et 
al. 2017). Besides, their biomechanical strength is better 
that synthetic materials in both in vitro and in vivo models 
(Schaner et al. 2004). Another investigation demonstrated 
that decellularization of arteries modified structural and 
elastic properties of the vessels, however the wall thickness 
remained the same. To compare with native arteries, 
decellularized arteries were larger, thinner and stiffer which 
able to accommodate high pressure before rupturing (Roy 
et al. 2005). To point out an ideal nerve conduit, certain 
criteria need to be fulfilled; sufficient mechanical strength, 
not easily collapse and presence of tubular lumen for nerve 
cells to grow. 
ISOLATION AND PROPAGATION OF HUMAN WHARTON’S 
JELLY MSCS (hWJMSCs)
hWJMSCs were successfully isolated using enzymatic 
digestion from the human umbilical cord sample. The 
mesenchymal stem cells isolated displayed homogenous, 
plastic adherence and bipolar spindle shaped morphology 
in monolayer cultures. In the early passage, the cells 
demonstrated more fibroblastic like appearance and spindle 
shaped morphology. Towards later passage, the cells 
were more enlarged and flattened (Figure 4). This could 
be due to long term in vitro expansion that contributes to 
cell maturing and aging (Neuhuber et al. 2008; Safwani 
et al. 2012; Zhuang et al. 2015). The use of hWJMSCs is 
said to be a desirable choice compared to other sources of 
mesenchymal stem cells such as bone marrow or peripheral 
blood because it is easily available and not a major ethical 
concern.
 According to previous study done, these cells possess 
unique characteristics of both human mesenchymal stem 
cells and human embryonic stem cells (ESC) based on 
immunophenotyping analysis. On the other hand, these 
cells lacked hematopoietic markers. Furthermore, these 
cells were able to differentiate into trilineage differentiation 
which is osteogenic, adipogenic and chondrogenic (Lim 
et al. 2016). The mentioned criteria, spindle shaped 
morphology, plastic adherence, express mesenchymal stem 
cells markers, lacked hematopoietic markers and capability 
of trilineage differentiation are the minimum criteria for 
mesenchymal stem cells (Dominici et al. 2006). Since 
similar isolation protocol and laboratory environment 
were being used in this experiment, it is assumed that 
mesenchymal stem cells isolated in this study possess the 
same characteristics. 
IMMUNOCYTOCHEMISTRY (ICC) ANALYSIS 
OF NEURODIFFERENTIATED MESENCHYMAL                             
STEM CELLS (ndMSCs)
The capability of mesenchymal stem cells to differentiate 
into several cells type of mesenchymal origin is well 
establish. On the other hand, mesenchymal stem cells also 
have the potential to differentiate into neuroectodermal 
lineage cells in the presence of neurotrophic factor 
(Jadalannagari et al. 2015; Wakao et al. 2014). After 
treated with 400 μg/mL of C. asiatica, neurodifferentiated 
mesenchymal stem cells (ndMSCs) showed the expression 
of S100β, P75 NGFR, MBP and GFAP markers in a similar 
manner with Schwann cells. As opposed to mesenchymal 
FIGURE 3. The decellularized HUC artery conduit did not degrade and swell after 12 weeks in 
incubation. A small change (11.8% ± 1.85) was observed on the decellularized HUC artery conduit
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stem cells, the only expression observed was in S100β 
marker, while no expression was observed in P75 NGFR, 
MBP and GFAP markers (Figure 5). The present findings in 
this study agreed with earlier study stated that minimal 
concentration of C. asiatica (400 μg/mL) has the capacity 
to differentiate hWJMSCs into Schwann cells or other 
neural lineage cells (Norazzila et al. 2018). 
 On the other hand, S100β is a calcium-binding protein 
concentrated in glial cells, however several studies have 
reported that this Schwann cells specific marker can be 
expressed by non-neural cells, such as mesenchymal 
stem cells, as what has been observed in this study 
(Deng et al. 2006; Michetti et al. 2012). Moreover, a 
study mentioned that S100β marker is not a very reliable 
marker for Schwann cells because early culture stage of 
Schwann cells did not express this marker. Similar study 
also reported that the expression of various Schwann cells 
related markers at different time point is necessary for 
the development of Schwann cells (Liu et al. 2015). In 
addition, the ability of C. asiatica to act as a neurotrophic 
FIGURE 4. Human Wharton’s Jelly MSCs from primary culture, passage 0 (P0) until expanded passages, passage 
4 (P4), as observed under phase contrast microscope. hWJMSCs demonstrated fibroblastic appearance and 
spindle shaped morphology in early culture and more flattened shape towards the late passages. 
Magnification, 10 × Scale bar, 100 μm 
FIGURE 5. Expression of S100β, P75 NGFR, MBP and GFAP were observed in the neurodifferentiated MSCs (ndMSCs) in a 
similar manner as Schwann cells. Meanwhile the expression of S100β was observed in MSCs, however the expression of 
P75 NGFR, MBP and GFAP were not observed in MSCs. The expressions of neural markers after induction of MSCs showed 
that MSCs were successfully neurodifferentiated by using 400 μg/mL of C. asiatica.  
Magnification, 10 × Scale bar, 100 μm 
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factor and induced the differentiation of mesenchymal 
stem cells into neural lineage cells might be attributed to 
the bioactive compounds present; mainly asiatic acid and 
madecassid asic (Puttarak et al. 2016) that play a major 
role in the enhancement of neurite outgrowth that happens 
after differentiation (Jiang et al. 2016; Wanakhachornkrai 
et al. 2013). 
IN VITRO EVALUATION OF CONSTRUCTED NERVE                       
CONDUIT (PRE-GRAFTING)
An ideal nerve conduit should support recellularization 
because the seeding of the cells into nerve conduit has 
been shown to be essential in promoting nerve regeneration 
(Kaizawa et al. 2017, 2016; Shalaby et al. 2017; Xu et al. 
2016). To test whether decellularized HUC artery conduit 
support recellularization, mesenchymal stem cells and 
neurodifferentiated mesenchymal stem cells (ndMSCs) 
were seeded into the luminal surface of the decellularized 
HUC artery and incubated for 2 days. After 2 days of 
incubation, H&E staining showed that the mesenchymal 
stem cells and ndMSCs adhered and spread well in the 
lumen and surface of the decellularized artery conduit 
(Figure 6). The seeded mesenchymal stem cells and 
ndMSCs did not become clump and form aggregation. 
The decellularized HUC artery conduit retained majority 
of extracellular matrix and support the cells seeded thus 
highlighted the good biocompatibility property. 
 The adherence of mesenchymal stem cells and 
ndMSCs on the vessels wall could be due to extracellular 
matrix collagen fibers that were preserved during 
decellularization. Extracellular matrix is an important 
component for cell adhesion, migration, proliferation and 
adaptive tissue responses (Badylak et al. 2009). Besides, 
the collagen fibers of an extracellular matrix scaffold 
play a vital role in determining its biocompatibility and 
biomechanical properties. As opposed to previous studies 
that reported about the success of seeding neuronal cell 
line and human umbilical vein endothelial cells into the 
decellularized HUC artery for nerve regeneration (Crouzier 
et al. 2009; Gui et al. 2009), in this study, the decellularized 
HUC artery supported the seeding of the mesenchymal stem 
cells and neurodifferentiated mesenchymal stem cells.
CONCLUSION
In this study, nerve conduit using decellularized HUC 
artery seeded with neurodifferentiated human MSCs 
(ndMSCs) was successfully developed. This study showed 
the potential utility of neurodifferentiated MSCs using 
C. asiatica for critical size peripheral nerve injury. This 
technique offers a promising approach in the development 
of nerve conduit and as an alternative strategy to the 
treatment of critical nerve defect. However, preclinical 
study needs to be done to see its effectiveness before it 
can be applied in clinical trial. 
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